Göbel, Andy https://orcid.org/0000-0003-0918-4064
Zinna, Valentina M.
Dell’Endice, Stefania
Jaschke, Nikolai
Kuhlmann, Jan Dominik
Wimberger, Pauline
Rachner, Tilman D.
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (GO 3055/1-1, RA 2151/4-1, RA 2151/5-1)
Deutsche Krebshilfe (#70113573, #70113573)
Article History
Received: 14 April 2020
Accepted: 10 July 2020
First Online: 29 July 2020
Ethics approval and consent to participate
: None of the used cell lines required ethics approval for their use.
: Not applicable.
: The authors have received grants or honorarium for advisory boards or lectures to the individual or the institution by Amgen (PW, TDR), AstraZeneca (PW), Novartis (PW, TDR), Pfizer (PW), Roche (PW), Tesaro (PW), PharmaMar (PW), TEVA (PW), and Merck (PW, TDR). AG, VMZ, SD, NJ, and JDK declare no conflict of interest.